Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2009
11/12/2009CA2728893A1 Inhibitors of syk protein kinase
11/12/2009CA2723148A1 Quinazoline derivatives
11/11/2009EP2116540A1 The salts of 4-aniline quinazoline derivative
11/11/2009EP2116523A1 Rexinoid compound having alkoxy group
11/11/2009EP2114902A2 Hiv inhibiting 5,6-substituted pyrimidines
11/11/2009EP2114901A1 Hiv inhibiting 6-substituted pyrimidines
11/11/2009EP2114900A1 Thiopyrimidine-based compounds and uses thereof
11/11/2009EP2114899A2 Controlled release of active aldehydes and ketones from equilibrated dynamic mixtures
11/11/2009EP2114157A1 Phosphoramidate alkylator prodrugs for the treatment of cancer
11/11/2009EP1943240B1 Chemical process
11/11/2009EP1917246B1 Benzoquinazoline derivatives and their use in treating bone disorders
11/11/2009EP1578731B1 Process for the preparation of pyrimidine compounds
11/11/2009EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009EP1397351B1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
11/11/2009EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009CN101578280A Benzoquinazole derivatives
11/11/2009CN101578273A Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
11/11/2009CN101575319A Process for preparing lapatinib synthetic intermediate
11/11/2009CN101575318A Novel dihydropyridine compound and application thereof on preparing drugs for curing and/or preventing virus diseases
11/11/2009CN101575303A Preparation method of 3- anilino-2-(3,4,5-trimethoxy benzyl) acrylonitrile
11/11/2009CN100558738C Fluorogenic enzyme substrates and methods of preparation
11/11/2009CN100558714C Method for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils
11/11/2009CN100558713C Pyridazine derivatives and their use as therapeutic agents
11/11/2009CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009US7615634 intermediate for synthesis an enzyme inhibitor of cyclin-dependent kinases, having antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors
11/10/2009US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents
11/10/2009US7615554 Erastin and erastin binding proteins, and uses thereof
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615552 Fused heterocyclic compounds
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009US7615542 Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV
11/10/2009CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/10/2009CA2378782C Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate
11/10/2009CA2371213C Inhibitors of carboxypeptidase u
11/10/2009CA2318296C Pyrimidine-2,4,6-trione compounds
11/05/2009WO2009134726A1 Substituted pyrimidine derivatives as histamine h4 receptor ligands
11/05/2009WO2009134658A2 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009WO2009133379A2 Antifungal target
11/05/2009WO2009089453A9 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
11/05/2009US20090275752 Novel Process for Statins and its Pharmaceutically Acceptable Salts Thereof
11/05/2009US20090275599 Therapeutic or prophylactic agent for multiple sclerosis
11/05/2009US20090275598 Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
11/05/2009US20090275572 Fab i inhibitors
11/05/2009US20090275565 Substituted aralkyl derivatives
11/05/2009US20090275556 Aryl sulfonamides useful as inhibitors of chemokine receptor activity
11/05/2009US20090275533 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009DE10108447B4 Nematische Flüssigkristallmischung und deren Verwendung in TN- und STN-Flüssigkristallanzeigen Nematic liquid crystal mixture and their use in TN and STN liquid crystal displays
11/05/2009CA2722220A1 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009CA2721959A1 Antifungal target
11/04/2009EP1727804B1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
11/04/2009EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/04/2009EP1533304B1 Amide derivative
11/04/2009EP1253152B1 Method of converting functional group through halogen-metal exchange reaction
11/04/2009CN101573343A HIV inhibiting 6-substituted pyrimidines
11/04/2009CN101573342A HIV inhibiting 5,6-substituted pyrimidines
11/04/2009CN101573333A Inhibitors of histone deacetylase
11/03/2009US7612203 Preparation of rosuvastatin having a low level of impurities by controlling the level of process impurities arising during the synthesis process; combining precursor compound having carboxyl protecting group with alcohol to obtain solution, cooling, treating with methanesulfonic acid
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612088 Heterocyclic compounds and their use as aldosterone synthase inhibitors
11/03/2009US7612077 Crystalline forms of the anti-cancer compound ZD1839
11/03/2009US7612068 (S)-1-{2-[2-(4-Fluoro-phenylsulfanyl)-phenoxy]-ethyl}-pyrrolidine-2-carboxylic acid; glycine transport inhibitors; for schizophrenia and other psychoses
11/03/2009US7612061 trans-1-{2-[(3,5-dibromobenzyl)oxy]-1,2,3,4-tetrahydronaphth-1-yl}-1,4-diazepane; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders
11/03/2009CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
11/03/2009CA2368834C Bicyclic heteroaromatic compounds useful as lh agonists
10/2009
10/29/2009WO2009132202A2 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009WO2009131687A2 Inhibitors of protein kinases
10/29/2009WO2009131173A1 2-aminoquinazoline derivative
10/29/2009WO2009131129A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009WO2009131127A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130496A1 Substituted pyrimidin-5-carboxamides 281
10/29/2009US20090270621 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
10/29/2009US20090270423 Antibacterial small molecules and methods for their synthesis
10/29/2009US20090270421 Inhibitors of fatty acid amide hydrolase
10/29/2009US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009US20090269354 Quinazoline derivatives and methods of treatment
10/29/2009US20090267026 Compound having hydrocoumarin skeleton, liquid crystal composition, and liquid crystal display device
10/29/2009CA2723185A1 Inhibitors of protein kinases
10/29/2009CA2722326A1 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722028A1 5-hydroxypyrimidine-4-carboxamide compound
10/29/2009CA2719936A1 Substituted pyrimidin-5-carboxamides 281
10/28/2009EP2112140A1 Chinazolin derivatives, medicine containing these compounds, application thereof and method for their production
10/28/2009EP2111395A1 New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
10/28/2009EP1272168B2 Small organic molecule regulators of cell proliferation
10/28/2009CN101565405A Sulfamethazine antigen, preparation method and application thereof
10/28/2009CN101565404A Heterocyclic compounds
10/28/2009CN100554245C Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2,6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile
10/27/2009US7608687 Releasable linkage and compositions containing same
10/27/2009US7608639 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009CA2493359C Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2415966C Tetrahydro-heterocycloazepinyl pyrimidine derivatives
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 427